Back
Creative Realities Vs. Novartis AG Industry Stock Comparison
Sell
26
CREX
Creative Realities
Last Price:
$1.93
Seasonality Move:
14.35%
Sell
47
NVSEF
Novartis AG
Last Price:
$107.20
Seasonality Move:
5.97%
Sell
26
Creative Realities (CREX)
is a Sell
Is Creative Realities a Buy, Sell or Hold?
-
The current Creative Realities [CREX] share price is $1.96. The Score for CREX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
CREX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Novartis AG (NVSEF)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.20. The Score for NVSEF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVSEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CREX Stock Price Chart
What is Creative Realities's stock price today?
-
The Creative Realities share price today is $1.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CREX is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing selling pressure, which indicates risk of future bearish movement.
CREX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.54 | Buy |
Relative Strength Index (14 RSI): | 43.59 | Sell |
Chaikin Money Flow: | -13417 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.82 - 2.2) | Sell |
Bollinger Bands (100): | (2.09 - 3.41) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.52 | Buy |
Relative Strength Index (14 RSI): | 45.11 | Sell |
Chaikin Money Flow: | -708751 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.53 - 115.13) | Sell |
Bollinger Bands (100): | (98.39 - 109.73) | Buy |
CREX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2 | Sell |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 2.27 | Sell |
200-day SMA: | 3.62 | Sell |
8-day EMA: | 1.65 | Buy |
20-day EMA: | 1.01 | Buy |
50-day EMA: | 0.49 | Buy |
200-day EMA: | 0.14 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.82 | Sell |
20-day SMA: | 111.72 | Sell |
50-day SMA: | 107.39 | Sell |
200-day SMA: | 107.05 | Buy |
8-day EMA: | 110.22 | Sell |
20-day EMA: | 110.51 | Sell |
50-day EMA: | 108.22 | Sell |
200-day EMA: | 105.09 | Buy |
Creative Realities Earnings Growth & CREX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Creative Realities Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |